Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sager

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
European Heart Journal. Acute Cardiovascular Care|September 1, 2021
Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trialJ J Coughlan, Alp Aytekin, Gjin Ndrepepa, et al.
Journal of the American Heart Association|December 14, 2022
Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes - A Post-hoc Analysis of the ISAR-REACT 5 TrialShqipdona Lahu, Maria Scalamogna, Gjin Ndrepepa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 25, 2025
Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosisJ Krefting, N Krüger, C Friess, et al.
International Journal of Cardiology|June 14, 2021
Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromesShqipdona Lahu, Gjin Ndrepepa, Senta Gewalt, et al.
Circulation|May 11, 2017
Functional Characterization of the <i>GUCY1A3</i> Coronary Artery Disease Risk LocusThorsten Kessler, Jana Wobst, Bernhard Wolf, et al.
The Journal of Experimental Medicine|March 25, 2015
Macrophages retain hematopoietic stem cells in the spleen via VCAM-1Partha Dutta, Friedrich Felix Hoyer, Lubov S Grigoryeva, et al.
Nature Cardiovascular Research|July 24, 2023
Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammationCarina Mauersberger, Hendrik B Sager, Jana Wobst, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 18, 2026
Impact of lipoprotein(a) on the durability of aortic bioprosthetic valvesFinn Syryca, Johannes Krefting, Elisabeth Oertel, et al.
Journal of the American College of Cardiology|June 15, 2019
Pro-Angiogenic Macrophage Phenotype to Promote Myocardial RepairBartolo Ferraro, Giovanna Leoni, Rabea Hinkel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 22, 2022
Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trialShqipdona Lahu, Gjin Ndrepepa, Franz-Josef Neumann, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
European Heart Journal. Acute Cardiovascular Care|September 1, 2021
Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trialJ J Coughlan, Alp Aytekin, Gjin Ndrepepa, et al.
Journal of the American Heart Association|December 14, 2022
Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes - A Post-hoc Analysis of the ISAR-REACT 5 TrialShqipdona Lahu, Maria Scalamogna, Gjin Ndrepepa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 25, 2025
Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosisJ Krefting, N Krüger, C Friess, et al.
International Journal of Cardiology|June 14, 2021
Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromesShqipdona Lahu, Gjin Ndrepepa, Senta Gewalt, et al.
Circulation|May 11, 2017
Functional Characterization of the <i>GUCY1A3</i> Coronary Artery Disease Risk LocusThorsten Kessler, Jana Wobst, Bernhard Wolf, et al.
The Journal of Experimental Medicine|March 25, 2015
Macrophages retain hematopoietic stem cells in the spleen via VCAM-1Partha Dutta, Friedrich Felix Hoyer, Lubov S Grigoryeva, et al.
Nature Cardiovascular Research|July 24, 2023
Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammationCarina Mauersberger, Hendrik B Sager, Jana Wobst, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 18, 2026
Impact of lipoprotein(a) on the durability of aortic bioprosthetic valvesFinn Syryca, Johannes Krefting, Elisabeth Oertel, et al.
Journal of the American College of Cardiology|June 15, 2019
Pro-Angiogenic Macrophage Phenotype to Promote Myocardial RepairBartolo Ferraro, Giovanna Leoni, Rabea Hinkel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 22, 2022
Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trialShqipdona Lahu, Gjin Ndrepepa, Franz-Josef Neumann, et al.
Pageof 13